Our Oligo Labeling Modifications services help research teams turn custom DNA and RNA sequences into assay-ready reagents with defined signal, capture, conjugation, or targeting functions. We support 5', 3', and internal oligonucleotide labeling strategies for fluorescent dyes, quenchers, biotin, amino, thiol, spacer-assisted labels, hydrophobic conjugates, and other project-specific modifications used in detection, imaging, pull-down, biosensor, and molecular interaction workflows.
From early design review through synthesis, purification, analytical verification, and delivery planning, our platform is built for customers who need more than a catalog modification list. We help align label chemistry with sequence behavior, assay format, linker architecture, purification requirements, and downstream handling so labeled oligos are easier to integrate into research and development programs. For broader chemistry support, we can also align projects with our oligo modification services and oligonucleotide conjugation services.
Weak Signal or High Background: A labeled oligo is only useful when the reporter chemistry fits the readout system. We help clients choose between single-label and dual-labeled formats, review reporter and quencher compatibility, and plan label placement so fluorescence output, background control, and multiplexing behavior are aligned with the assay rather than left to trial and error.
Capture and Immobilization Bottlenecks: Many projects fail not because the sequence is wrong, but because the capture tag is poorly exposed or the surface chemistry is not matched to the experimental format. We support biotin labeling of oligonucleotides, spacer selection, and attachment-strategy review for bead capture, plate immobilization, enrichment, and pull-down workflows.
Conjugation Compatibility Issues: Amino-, thiol-, and click-enabled oligos are often ordered for downstream dye, ligand, protein, or nanoparticle coupling, but performance depends on linker choice, protection strategy, and reactive-group accessibility. We help teams plan functional handles that are compatible with their intended conjugation route instead of creating expensive redesign cycles after synthesis.
Purity Loss in Multi-Modified Designs: As label complexity increases, synthesis difficulty, hydrophobicity, and purification burden also increase. We evaluate sequence length, modification density, and label type to recommend a realistic route for synthesis, purification, and QC, especially for fluorescent, quenched, hydrophobic, and specialty-labeled oligos.
Fragmented Outsourcing and Slow Project Handoffs: Customers often need one supplier for sequence review, label incorporation, purification, and documentation rather than separate vendors for each step. Our workflow integrates technical assessment, labeled oligo production, analytical release, and project-specific support so procurement and scientific teams can move from inquiry to experimental use more efficiently.
Our service portfolio is designed for biotech companies, pharmaceutical discovery teams, diagnostics developers, CROs, and academic laboratories that need labeled oligos matched to a defined experimental purpose. We support both standard and custom labeling programs across DNA, RNA, and modified oligonucleotide formats.
Rather than treating labeling as an isolated add-on, we review sequence context, modification position, linker needs, purification route, analytical expectations, and downstream chemistry so the final construct is more likely to perform as intended.
| Labeling | Short Code | Price |
| 3-Biotin | 3'-Bi | Inquiry |
| 3'-Cholesterol | 3'-Chl | Inquiry |
| 3'-Cy3 | Cy3-3' | Inquiry |
| 3'-Cy5 | Cy5-3' | Inquiry |
| 3'-Cy5.5 | Cy5.5-3' | Inquiry |
| 3'-DY547 (Cy3 Alternative) | DY547-3' | Inquiry |
| 3'-Biotin LC | 3'-LCBi | Inquiry |
| 3'-Biotin LC LC | 3'-2LCBi | Inquiry |
| 3'-Puromycin | Pmn | Inquiry |
| 3'-TAMRA | 3'-TAM | Inquiry |
| 5'-Biotin | Bi | Inquiry |
| 5'-Cholesterol | Chl | Inquiry |
| 5'-Cy3 | Cy3 | Inquiry |
| 5'-Cy5 | Cy5 | Inquiry |
| 5'-Cy5.5 | Cy5.5 | Inquiry |
| 5'-Dabcyl | Dabcyl | Inquiry |
| 5-DY547 (Cy3 Alternative) | DY547 | Inquiry |
| 5'-DY647 (Cy5 Alternative) | DY647 | Inquiry |
| 5'-DY677 (Cy5.5 Alternative) | DY677 | Inquiry |
| 5'-Pyrene | 5'-Pyr | Inquiry |
The table below helps project teams compare common oligo labeling families by function, placement logic, and decision points that typically influence synthesis feasibility and downstream performance.
| Label Family | Primary Function | Typical Positions | Key Selection Factors | Representative Uses |
| Fluorescent Labels | Generate optical signal for detection or imaging | 5', 3', internal | Instrument compatibility, dye brightness, spectral overlap, linker burden | FISH, hybridization assays, fluorescent probes, target visualization |
| Reporter-Quencher Pairs | Enable low-background signal generation in probe systems | Usually terminal with design-specific internal options | Reporter/quencher pairing, assay format, Tm balance, multiplex strategy | Hydrolysis probes, molecular beacons, FRET assays |
| Biotin Tags | Support affinity capture and immobilization | 5', 3', internal | Spacer length, steric accessibility, surface format, capture workflow | Pull-down, enrichment, bead capture, plate or membrane immobilization |
| Amino Labels | Provide a reactive amine for post-synthesis coupling | 5', 3', internal | Linker length, coupling route, surface chemistry, payload size | NHS coupling, surface attachment, custom dye or biomolecule conjugation |
| Thiol Labels | Provide a sulfhydryl handle for covalent attachment | 5', 3', internal | Protected state, reduction requirements, maleimide or gold chemistry | Biosensors, nanoparticles, surface assembly, conjugate construction |
| Click-Ready Handles | Enable modular and selective post-labeling | Commonly 5' or internal, with project-specific alternatives | Copper-free vs copper-assisted route, site control, linker geometry | Dye, peptide, ligand, polymer, and custom payload conjugation |
| Hydrophobic Labels | Add membrane affinity or alter formulation behavior | Mostly terminal | Solubility, aggregation risk, purification route, spacer need | Cholesterol-, tocopherol-, and stearyl-labeled oligos |
| Specialty Labels | Add assay-specific or platform-specific functionality | Position-dependent | Detection method, photoactivity, redox behavior, custom feasibility | Psoralen, rhodamine, cyanine, ferrocene, isotope, methylene blue systems |
Successful oligo labeling projects depend on more than the label name itself. This planning matrix summarizes the main technical inputs that affect synthesis success, purification strategy, analytical confidence, and downstream usability.
| Planning Factor | Why It Matters | Common Project Questions | Our Review Focus | Typical Output |
| Sequence and Length | Base composition and oligo length affect synthesis efficiency and final purity | Is the sequence difficult, repetitive, GC-rich, or highly structured? | Sequence feasibility, modification tolerance, expected purification burden | Fit-for-purpose synthesis plan |
| Label Position | 5', 3', and internal placements can change accessibility and assay performance | Should the label be terminal, internal, or dual-positioned? | Attachment site logic, target recognition impact, steric exposure | Position recommendation |
| Linker and Spacer | Spacer architecture often determines whether a label is actually usable in the assay | Is a short linker enough, or is extra distance needed from the hybridizing region? | Spacer length, flexibility, accessibility, surface presentation | Linker strategy selection |
| Purification Route | Label chemistry and hydrophobicity strongly affect recovery and full-length enrichment | Is desalting enough, or should HPLC or other higher-stringency purification be used? | Label sensitivity, multi-modification complexity, recovery versus purity tradeoff | Recommended purification pathway |
| Scale and Format | Project stage determines material quantity, concentration, and packaging needs | Is the oligo for screening, assay optimization, or repeated batch use? | Requested amount, aliquoting needs, reconstitution preferences | Delivery format plan |
| Analytical Package | Labeled oligos require confirmation of both oligo identity and label incorporation | What evidence is needed before the reagent moves into the next study stage? | Identity, purity, modification confirmation, project-specific documentation | QC and release documentation |
| Downstream Chemistry | Reactive-handle projects can fail when the follow-on coupling route is not planned in advance | Will the oligo be further conjugated to a dye, peptide, protein, lipid, or surface? | Reactive-group compatibility, protection strategy, coupling workflow fit | Conjugation-ready design |
| Application Context | The same label can behave very differently across qPCR, imaging, capture, and surface workflows | What instrument, matrix, or assay environment will the oligo actually face? | Assay context, readout logic, practical use constraints | Application-aligned recommendation |
Our workflow is designed for customers who need a practical path from modification idea to labeled oligo delivery, with technical checkpoints that reduce redesign risk and make project handoff easier for both scientific and procurement teams.
We begin by reviewing the sequence, oligo type, intended application, preferred label, modification position, scale, and delivery expectations. This step helps determine whether the project is best served by a direct label, a reactive handle, a dual-labeled design, or a broader conjugation workflow.
We evaluate sequence length, composition, structure tendency, and the practical effect of placing the modification at the 5', 3', or internal position. Where needed, we also assess spacer needs, dual-label spacing, and whether the modification could interfere with hybridization or downstream handling.
Once the construct logic is clear, we define the most suitable labeling route, such as direct incorporation during synthesis, protected-handle installation for later coupling, or a post-synthesis conjugation strategy. Purification level and analytical expectations are also aligned at this stage.
The oligo is synthesized with the agreed label or reactive modification under conditions matched to sequence difficulty and modification burden. For complex or hydrophobic constructs, additional planning is applied to maintain full-length recovery and prepare the material for clean downstream processing.
Purification is selected according to construct complexity, dye or tag chemistry, and use requirements. We then verify key release attributes such as identity, purity, and modification incorporation so teams receive material with a technical basis for experimental deployment.
Final materials are delivered with the agreed documentation and handling guidance. For projects involving downstream conjugation, assay transfer, or platform development, we can also support follow-on discussions around spacer optimization, additional modification combinations, or next-round construct refinement.
Customers choose our platform when they need labeling support that connects chemistry decisions with real experimental use. We focus on technical relevance, modification feasibility, and practical deliverables rather than presenting labels as interchangeable catalog items.
Labeled oligos are used across a wide range of research and assay development settings where a native sequence must be converted into a detectable, capture-ready, or conjugation-ready tool. Our services are structured around these application realities rather than around label names alone.
Whether you need a fluorescent probe, a dual-labeled assay oligo, a biotin capture sequence, a reactive-handle construct, or a specialty-labeled custom design, our team can help you move from sequence concept to labeled material with a clearer technical path. We work with research organizations that need help selecting the right label, defining the right position, planning purification, and preparing a construct that fits downstream workflows. Contact us to discuss your sequence, label type, modification position, scale, purification target, and application requirements.
A quencher suppresses fluorescence in labeled probes until target binding occurs. This enables real-time detection in applications like qPCR and molecular beacons.
Select based on your fluorophore's emission spectrum; BHQ offers broadest coverage and lowest background. We recommend optimal quencher-fluorophore pairs for your specific assay.
Yes, we offer comprehensive 3' and 5' modifications including biotin, cholesterol, and various fluorophores. Our platform ensures precise positioning of your required labels.
We provide DY547 as Cy3 alternative and DY647 as Cy5 alternative with comparable performance. These options deliver similar spectral properties at reduced cost.
We optimize coupling conditions for each modification type and verify results through HPLC and MS analysis. This guarantees high labeling efficiency and product purity.
